4.5 Article

Heterogeneity of the HIV epidemic in agrarian, trading, and fishing communities in Rakai, Uganda: an observational epidemiological study

期刊

LANCET HIV
卷 3, 期 8, 页码 E388-E396

出版社

ELSEVIER INC
DOI: 10.1016/S2352-3018(16)30034-0

关键词

-

资金

  1. National Institute of Mental Health [K23MH086338, R01MH107275]
  2. National Institute of Allergy and Infectious Diseases [U01AI100031, R01AI110324, R01AI102939]
  3. National Institute of Child Health and Development [RO1HD070769, R01HD050180]
  4. National Institute for Allergy and Infectious Diseases Division of Intramural Research, National Institutes of Health
  5. Bill & Melinda Gates Foundation [22006.02]
  6. Johns Hopkins University Center for AIDS Research [P30AI094189]

向作者/读者索取更多资源

Background Understanding the extent to which HIV burden differs across communities and the drivers of local disparities is crucial for an effective and targeted HIV response. We assessed community-level variations in HIV prevalence, risk factors, and treatment and prevention service uptake in Rakai, Uganda. Methods The Rakai Community Cohort Study (RCCS) is an open, population-based cohort of people aged 15-49 years in 40 communities. Participants are HIV tested and interviewed to obtain sociodemographic, behavioural, and health information. RCCS data from Aug 10, 2011, to May 30, 2013, were used to classify communities as agrarian (n=27), trading (n=9), or lakeside fishing sites (n=4). We mapped HIV prevalence with Bayesian methods, and characterised variability across and within community classifications. We also assessed differences in HIV risk factors and uptake of antiretroviral therapy and male circumcision between community types. Findings 17119 individuals were included, 9215 (54%) of whom were female. 9931 participants resided in agrarian, 3318 in trading, and 3870 in fishing communities. Median HIV prevalence was higher in fishing communities (42%, range 38-43) than in trading (17%, 11-21) and agrarian communities (14%, 9-26). Antiretroviral therapy use was significantly lower in both men and women in fishing communities than in trading (age-adjusted prevalence risk ratio in men 0.64, 95% CI 0.44-0.97; women 0.53, 0.42-0.66) and agrarian communities (men 0.55, 0. 42-0.72; women 0.65, 0.54-0.79), as was circumcision coverage among men (vs trading 0.48, 0.42-0.55; vs agrarian 0.64, 0.56-0.72). Self-reported risk behaviours were significantly higher in men than in women and in fishing communities than in other community types. Interpretation Substantial heterogeneity in HIV prevalence, risk factors, and service uptake in Rakai, Uganda, emphasises the need for local surveillance and the design of targeted HIV responses. High HIV burden, risk behaviours, and low use of combination HIV prevention in fishing communities make these populations a priority for intervention.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Oncology

The human microbiome and its link in prostate cancer risk and pathogenesis

Paul Katongole, Obondo J. Sande, Moses Joloba, Steven J. Reynolds, Nixon Niyonzima

INFECTIOUS AGENTS AND CANCER (2020)

Article Biology

Lives saved with vaccination for 10 pathogens across 112 countries in a pre-COVID-19 world

Jaspreet Toor, Susy Echeverria-Londono, Xiang Li, Kaja Abbas, Emily D. Carter, Hannah E. Clapham, Andrew Clark, Margaret J. de Villiers, Kirsten Eilertson, Matthew Ferrari, Ivane Gamkrelidze, Timothy B. Hallett, Wes R. Hinsley, Daniel Hogan, John H. Huber, Michael L. Jackson, Kevin Jean, Mark Jit, Andromachi Karachaliou, Petra Klepac, Alicia Kraay, Justin Lessler, Xi Li, Benjamin A. Lopman, Tewodaj Mengistu, C. Jessica E. Metcalf, Sean M. Moore, Shevanthi Nayagam, Timos Papadopoulos, T. Alex Perkins, Allison Portnoy, Homie Razavi, Devin Razavi-Shearer, Stephen Resch, Colin Sanderson, Steven Sweet, Yvonne Tam, Hira Tanvir, Quan Tran Minh, Caroline L. Trotter, Shaun A. Truelove, Emilia Vynnycky, Neff Walker, Amy Winter, Kim Woodruff, Neil M. Ferguson, Katy A. M. Gaythorpe

Summary: Vaccination activities from 2000 to 2030 are estimated to prevent 97 million deaths, with additional benefits for children under 5. This study motivates the sustaining and improvement of global vaccination coverage in the future.
Article Microbiology

Over 100 Years of Rift Valley Fever: A Patchwork of Data on Pathogen Spread and Spillover

Gebbiena M. Bron, Kathryn Strimbu, Helene Cecilia, Anita Lerch, Sean M. Moore, Quan Tran, T. Alex Perkins, Quirine A. ten Bosch

Summary: Over the past 100 years, Rift Valley fever virus (RVFV) has caused potentially lethal diseases in both animals and humans in various countries, indicating an increased risk of transmission. The study found that in 24 countries, detection of RVFV antibodies in animals or humans was common, suggesting that the transmission of RVFV may go unnoticed.

PATHOGENS (2021)

Article Infectious Diseases

Impacts of K-12 school reopening on the COVID-19 epidemic in Indiana, USA

Guido Espana, Sean Cavany, Rachel Oidtman, Carly Barbera, Alan Costello, Anita Lerch, Marya Poterek, Quan Tran, Annaliese Wieler, Sean Moore, T. Alex Perkins

Summary: The study found that the operating capacity and face-mask adherence in schools have a significant impact on the number of infections and deaths related to COVID-19. Remote operation of schools can significantly reduce the risk of epidemic spread, while high operating capacity and low face-mask adherence may lead to a surge in infections and deaths.

EPIDEMICS (2021)

Article Infectious Diseases

The current burden of Japanese encephalitis and the estimated impacts of vaccination: Combining estimates of the spatial distribution and transmission intensity of a zoonotic pathogen

Sean M. Moore

Summary: Japanese encephalitis continues to be a significant public health concern in Asia, with over one billion people estimated to live in areas suitable for local transmission of the Japanese encephalitis virus (JEV). Increases in vaccination coverage have led to a decrease in incidence and deaths from JE over the past decade, preventing hundreds of thousands of cases and deaths. The study highlights the need for targeted efforts to improve vaccination coverage in countries with high JE burden.

PLOS NEGLECTED TROPICAL DISEASES (2021)

Article Multidisciplinary Sciences

Burden is in the eye of the beholder: Sensitivity of yellow fever disease burden estimates to modeling assumptions

T. Alex Perkins, John H. Huber, Quan M. Tran, Rachel J. Oidtman, Magdalene K. Walters, Amir S. Siraj, Sean M. Moore

Summary: Estimates of disease burden are crucial for public health priorities, but uncertainties are high. When estimating the burden of yellow fever in Africa, alternative interpretations of data and statistical uncertainties play significant roles, highlighting the need for improved surveillance.

SCIENCE ADVANCES (2021)

Article Multidisciplinary Sciences

Evaluation of individual and ensemble probabilistic forecasts of COVID-19 mortality in the United States

Estee Y. Cramer, Evan L. Ray, Velma K. Lopez, Johannes Bracher, Andrea Brennen, Alvaro J. Castro Rivadeneira, Aaron Gerding, Tilmann Gneiting, Katie H. House, Yuxin Huang, Dasuni Jayawardena, Abdul H. Kanji, Ayush Khandelwal, Khoa Le, Anja Muhlemann, Jarad Niemi, Apurv Shah, Ariane Stark, Yijin Wang, Nutcha Wattanachit, Martha W. Zorn, Youyang Gu, Sansiddh Jain, Nayana Bannur, Ayush Deva, Mihir Kulkarni, Srujana Merugu, Alpan Raval, Siddhant Shingi, Avtansh Tiwari, Jerome White, Neil F. Abernethy, Spencer Woody, Maytal Dahan, Spencer Fox, Kelly Gaither, Michael Lachmann, Lauren Ancel Meyers, James G. Scott, Mauricio Tec, Ajitesh Srivastava, Glover E. George, Jeffrey C. Cegan, Ian D. Dettwiller, William P. England, Matthew W. Farthing, Robert H. Hunter, Brandon Lafferty, Igor Linkov, Michael L. Mayo, Matthew D. Parno, Michael A. Rowland, Benjamin D. Trump, Yanli Zhang-James, Samuel Chen, Stephen Faraone, Jonathan Hess, Christopher P. Morley, Asif Salekin, Dongliang Wang, Sabrina M. Corsetti, Thomas M. Baer, Marisa C. Eisenberg, Karl Falb, Yitao Huang, Emily T. Martin, Ella McCauley, Robert L. Myers, Tom Schwarz, Daniel Sheldon, Graham Casey Gibson, Rose Yu, Liyao Gao, Yian Ma, Dongxia Wu, Xifeng Yan, Xiaoyong Jin, Yu-Xiang Wang, YangQuan Chen, Lihong Guo, Yanting Zhao, Quanquan Gu, Jinghui Chen, Lingxiao Wang, Pan Xu, Weitong Zhang, Difan Zou, Hannah Biegel, Joceline Lega, Steve McConnell, V. P. Nagraj, Stephanie L. Guertin, Christopher Hulme-Lowe, Stephen D. Turner, Yunfeng Shi, Xuegang Ban, Robert Walraven, Qi-Jun Hong, Stanley Kong, Axel van de Walle, James A. Turtle, Michal Ben-Nun, Steven Riley, Pete Riley, Ugur Koyluoglu, David DesRoches, Pedro Forli, Bruce Hamory, Christina Kyriakides, Helen Leis, John Milliken, Michael Moloney, James Morgan, Ninad Nirgudkar, Gokce Ozcan, Noah Piwonka, Matt Ravi, Chris Schrader, Elizabeth Shakhnovich, Daniel Siegel, Ryan Spatz, Chris Stiefeling, Barrie Wilkinson, Alexander Wong, Sean Cavany, Guido Espana, Sean Moore, Rachel Oidtman, Alex Perkins, David Kraus, Andrea Kraus, Zhifeng Gao, Jiang Bian, Wei Cao, Juan Lavista Ferres, Chaozhuo Li, Tie-Yan Liu, Xing Xie, Shun Zhang, Shun Zheng, Alessandro Vespignani, Matteo Chinazzi, Jessica T. Davis, Kunpeng Mu, Ana Pastore Y. Piontti, Xinyue Xiong, Andrew Zheng, Jackie Baek, Vivek Farias, Andreea Georgescu, Retsef Levi, Deeksha Sinha, Joshua Wilde, Georgia Perakis, Mohammed Amine Bennouna, David Nze-Ndong, Divya Singhvi, Ioannis Spantidakis, Leann Thayaparan, Asterios Tsiourvas, Arnab Sarker, Ali Jadbabaie, Devavrat Shah, Nicolas Della Penna, Leo A. Celi, Saketh Sundar, Russ Wolfinger, Dave Osthus, Lauren Castro, Geoffrey Fairchild, Isaac Michaud, Dean Karlen, Matt Kinsey, Luke C. Mullany, Kaitlin Rainwater-Lovett, Lauren Shin, Katharine Tallaksen, Shelby Wilson, Elizabeth C. Lee, Juan Dent, Kyra H. Grantz, Alison L. Hill, Joshua Kaminsky, Kathryn Kaminsky, Lindsay T. Keegan, Stephen A. Lauer, Joseph C. Lemaitre, Justin Lessler, Hannah R. Meredith, Javier Perez-Saez, Sam Shah, Claire P. Smith, Shaun A. Truelove, Josh Wills, Maximilian Marshall, Lauren Gardner, Kristen Nixon, John C. Burant, Lily Wang, Lei Gao, Zhiling Gu, Myungjin Kim, Xinyi Li, Guannan Wang, Yueying Wang, Shan Yu, Robert C. Reiner, Ryan Barber, Emmanuela Gakidou, Simon Hay, Steve Lim, Chris Murray, David Pigott, Heidi L. Gurung, Prasith Baccam, Steven A. Stage, Bradley T. Suchoski, B. Aditya Prakash, Bijaya Adhikari, Jiaming Cui, Alexander Rodriguez, Anika Tabassum, Jiajia Xie, Pinar Keskinocak, John Asplund, Arden Baxter, Buse Eylul Oruc, Nicoleta Serban, Sercan O. Arik, Mike Dusenberry, Arkady Epshteyn, Elli Kanal, Long T. Le, Chun-Liang Li, Tomas Pfister, Dario Sava, Rajarishi Sinha, Thomas Tsai, Nate Yoder, Jinsung Yoon, Leyou Zhang, Sam Abbott, Nikos Bosse, Sebastian Funk, Joel Hellewell, Sophie R. Meakin, Katharine Sherratt, Mingyuan Zhou, Rahi Kalantari, Teresa K. Yamana, Sen Pei, Jeffrey Shaman, Michael L. Li, Dimitris Bertsimas, Omar Skali Lami, Saksham Soni, Hamza Tazi Bouardi, Turgay Ayer, Madeline Adee, Jagpreet Chhatwal, Ozden O. Dalgic, Mary A. Ladd, Benjamin P. Linas, Peter Mueller, Jade Xiao, Yuanjia Wang, Qinxia Wang, Shanghong Xie, Donglin Zeng, Alden Green, Jacob Bien, Logan Brooks, Addison J. Hu, Maria Jahja, Daniel McDonald, Balasubramanian Narasimhan, Collin Politsch, Samyak Rajanala, Aaron Rumack, Noah Simon, Ryan J. Tibshirani, Rob Tibshirani, Valerie Ventura, Larry Wasserman, Eamon B. O'Dea, John M. Drake, Robert Pagano, Quoc T. Tran, Lam Si Tung Ho, Huong Huynh, Jo W. Walker, Rachel B. Slayton, Michael A. Johansson, Matthew Biggerstaff, Nicholas G. Reich

Summary: Short-term probabilistic forecasts of the COVID-19 pandemic in the United States have been crucial in communication between scientists and the public and decision-makers. The US COVID-19 Forecast Hub collected millions of predictions from various academic, industry, and independent research groups, providing accurate forecasts for short-term decision-making. Collaboration between government agencies, academic modeling teams, and industry partners plays a significant role in developing modeling capabilities to support outbreak response at different levels.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Article Medicine, General & Internal

Projecting vaccine demand and impact for emerging zoonotic pathogens

Anita Lerch, Quirine A. Ten Bosch, Maina L'Azou Jackson, Alison A. Bettis, Mauro Bernuzzi, Georgina A. Murphy, Quan M. Tran, John H. Huber, Amir S. Siraj, Gebbiena M. Bron, Margaret Elliott, Carson S. Hartlage, Sojung Koh, Kathyrn Strimbu, Magdalene Walters, T. Alex Perkins, Sean M. Moore

Summary: In order to respond effectively to potential outbreaks of emerging zoonotic diseases, vaccines are being developed for prioritized pathogens. Vaccination strategies targeting healthcare workers have shown to have a higher impact compared to population-wide vaccination. The current estimates are based on the epidemiology of each pathogen, but uncertainties and evolution of pathogens may alter vaccine stockpile requirements in the future.

BMC MEDICINE (2022)

Article Biochemical Research Methods

Prioritizing interventions for preventing COVID-19 outbreaks in military basic training

Guido Espana, T. Alex Perkins, Simon D. Pollett, Morgan E. Smith, Sean M. Moore, Paul O. Kwon, Tara L. Hall, Milford H. Beagle, Clinton K. Murray, Shilpa Hakre, Sheila A. Peel, Kayvon Modjarrad, Paul T. Scott

Summary: This study presents a simulation model of COVID-19 outbreaks in a U.S. Army basic training setting and provides practical approaches to improve prevention. The findings suggest that virus introductions from trainers pose a greater risk than the number of trainees, and the risk of outbreaks is highly influenced by false-positive results during entry testing. These findings offer practical recommendations to prevent COVID-19 outbreaks in basic training and ensure a continuous flow of new soldiers. The study highlights the importance of bespoke modeling to inform prevention in diverse institutional settings.

PLOS COMPUTATIONAL BIOLOGY (2022)

Article Immunology

Expected endpoints from future chikungunya vaccine trial sites informed by serological data and modeling

Tran Quan Minh, James Soda, Amir Siraj, Sean Moore, Hannah Clapham, T. Alex Perkins

Summary: There has been an increased interest in developing a vaccine for chikungunya in recent decades due to its unpredictable transmission. To inform decision making on vaccine trials, a new framework was developed to project the expected number of endpoint events at a given site using serological data and an SIR transmission model. The results suggest that some sites may have sufficient transmission potential and susceptibility to support future vaccine trials.

VACCINE (2023)

Article Health Care Sciences & Services

Impact of SARS-CoV-2 vaccination of children ages 5-11 years on COVID-19 disease burden and resilience to new variants in the United States, November 2021-March 2022: A multi-model study

Rebecca K. Borchering, Luke C. Mullany, Emily Howerton, Matteo Chinazzi, Claire P. Smith, Michelle Qin, Nicholas G. Reich, Lucie Contamin, John Levander, Jessica Kerr, J. Espino, Harry Hochheiser, Kaitlin Lovett, Matt Kinsey, Kate Tallaksen, Shelby Wilson, Lauren Shin, Joseph C. Lemaitre, Juan Dent Hulse, Joshua Kaminsky, Elizabeth C. Lee, Alison L. Hill, Jessica T. Davis, Kunpeng Mu, Xinyue Xiong, Ana Pastore Y. Piontti, Alessandro Vespignani, Ajitesh Srivastava, Przemyslaw Porebski, Srini Venkatramanan, Aniruddha Adiga, Bryan Lewis, Brian Klahn, Joseph Outten, Benjamin Hurt, Jiangzhuo Chen, Henning Mortveit, Amanda Wilson, Madhav Marathe, Stefan Hoops, Parantapa Bhattacharya, Dustin Machi, Shi Chen, Rajib Paul, Daniel Janies, Jean-Claude Thill, Marta Galanti, Teresa Yamana, Sen Pei, Jeffrey Shaman, Guido Espana, Sean Cavany, Sean Moore, Alex Perkins, Jessica M. Healy, Rachel B. Slayton, Michael A. Johansson, Matthew Biggerstaff, Katriona Shea, Shaun A. Truelove, Michael C. Runge, Cecile Viboud, Justin Lessler

Summary: This study examined the impact of expanding COVID-19 vaccination to children aged 5-11 years on disease burden and resilience against variant strains. The results showed that vaccinating children can significantly reduce cases, hospitalizations, and deaths, with greater benefits for children in particular.

LANCET REGIONAL HEALTH-AMERICAS (2023)

Article Medicine, General & Internal

Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study

Xiang Li, Christinah Mukandavire, Zulma M. Cucunuba, Susy Echeverria Londono, Kaja Abbas, Hannah E. Clapham, Mark Jit, Hope L. Johnson, Timos Papadopoulos, Emilia Vynnycky, Marc Brisson, Emily D. Carter, Andrew Clark, Margaret J. de Villiers, Kirsten Eilertson, Matthew J. Ferrari, Ivane Gamkrelidze, Katy A. M. Gaythorpe, Nicholas C. Grassly, Timothy B. Hallett, Wes Hinsley, Michael L. Jackson, Kevin Jean, Andromachi Karachaliou, Petra Klepac, Justin Lessler, Xi Li, Sean M. Moore, Shevanthi Nayagam, Duy Manh Nguyen, Homie Razavi, Devin Razavi-Shearer, Stephen Resch, Colin Sanderson, Steven Sweet, Stephen Sy, Yvonne Tam, Hira Tanvir, Quan Minh Tran, Caroline L. Trotter, Shaun Truelove, Kevin van Zandvoort, Stephane Verguet, Neff Walker, Amy Winter, Kim Woodruff, Neil M. Ferguson, Tini Garske

Summary: The study estimates that vaccination against ten selected pathogens will have averted 69 million deaths between 2000 and 2030, with a significant impact on reducing mortality among children under 5 years old, especially from measles. The introduction of new vaccines and increases in vaccine coverage are predicted to result in a 72% reduction in lifetime mortality in the 2019 birth cohort.

LANCET (2021)

Article Immunology

Neurocognitive Effects of Antiretroviral Initiation Among People Living With HIV in Rural Uganda

Alyssa Vecchio, Kevin Robertson, Deanna Saylor, Gertrude Nakigozi, Noeline Nakasujja, Alice Kisakye, James Batte, Richard Mayanja, Aggrey Anok, Steven J. Reynolds, Thomas C. Quinn, Ronald Gray, Maria J. Wawer, Ned Sacktor, Leah H. Rubin

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2020)

Article Demography

Population-level adult mortality following the expansion of antiretroviral therapy in Rakai, Uganda

Dorean Nabukalu, Georges Reniers, Kathryn A. Risher, Sylvia Blom, Emma Slaymaker, Chodziwadziwa Kabudula, Basia Zaba, Fred Nalugoda, Godfrey Kigozi, Fred Makumbi, David Serwadda, Steven J. Reynolds, Milly Marston, Jeffrey W. Eaton, Ron Gray, Maria Wawer, Nelson Sewankambo, Tom Lutalo

POPULATION STUDIES-A JOURNAL OF DEMOGRAPHY (2020)

Article Health Policy & Services

Antiretroviral treatment sharing among highly mobile Ugandan fisherfolk living with HIV: a qualitative study

Joseph G. Rosen, Neema Nakyanjo, Dauda Isabirye, Maria J. Wawer, Fred Nalugoda, Steven J. Reynolds, Gertrude Nakigozi, M. Kathryn Grabowski, Caitlin E. Kennedy

AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV (2020)

暂无数据